Protein kinase
A protein kinase is a
Chemical activity
The chemical activity of a protein kinase involves removing a phosphate group from
Structure
Eukaryotic protein kinases are enzymes that belong to a very extensive family of proteins that share a conserved catalytic core.[5][6][7][8] The structures of over 280 human protein kinases have been determined.[9]
There are a number of conserved regions in the catalytic domain of protein kinases. In the
Serine/threonine-specific protein kinases
Serine/threonine protein kinases (EC 2.7.11.1) phosphorylate the OH group of serine or threonine (which have similar side chains). Activity of these protein kinases can be regulated by specific events (e.g., DNA damage), as well as numerous chemical signals, including cAMP/cGMP, diacylglycerol, and Ca2+/calmodulin. One very important group of protein kinases are the
Tyrosine-specific protein kinases
Tyrosine-specific protein kinases (EC 2.7.10.1 and EC 2.7.10.2) phosphorylate tyrosine amino acid residues, and like serine/threonine-specific kinases are used in signal transduction. They act primarily as growth factor receptors and in downstream signaling from growth factors.[11] Some examples include:
- Platelet-derived growth factor receptor (PDGFR)
- Epidermal growth factor receptor (EGFR)[12]
- Insulin receptor and insulin-like growth factor 1 receptor (IGF1R)
- Stem cell factor (SCF) receptor (also called c-kit, see the article on gastrointestinal stromal tumor).
Receptor tyrosine kinases
These kinases consist of extracellular domains, a transmembrane spanning alpha helix, and an intracellular tyrosine kinase domain protruding into the cytoplasm. They play important roles in regulating cell division, cellular differentiation, and morphogenesis. More than 50 receptor tyrosine kinases are known in mammals.
Structure
The extracellular domains serve as the
Regulation
Ligand binding causes two reactions:
- Dimerization of two monomeric receptor kinases or stabilization of a loose dimer. Many ligands of receptor tyrosine kinases are multivalent. Some tyrosine receptor kinases (e.g., the platelet-derived growth factor receptor) can form heterodimers with other similar but not identical kinases of the same subfamily, allowing a highly varied response to the extracellular signal.
- Trans-autophosphorylation (phosphorylation by the other kinase in the dimer) of the kinase.
Autophosphorylation stabilizes the active conformation of the kinase domain. When several amino acids suitable for phosphorylation are present in the kinase domain (e.g., the insulin-like growth factor receptor), the activity of the kinase can increase with the number of phosphorylated amino acids; in this case, the first phosphorylation switches the kinase from "off" to "standby".
Signal transduction
The active tyrosine kinase phosphorylates specific target proteins, which are often enzymes themselves. An important target is the
Receptor-associated tyrosine kinases
Tyrosine kinases recruited to a receptor following hormone binding are receptor-associated tyrosine kinases and are involved in a number of signaling cascades, in particular those involved in
Dual-specificity protein kinases
Some kinases have
Histidine-specific protein kinases
Histidine kinases are found widely in prokaryotes, as well as in plants, fungi and eukaryotes. The pyruvate dehydrogenase family of kinases in animals is structurally related to histidine kinases, but instead phosphorylate serine residues, and probably do not use a phospho-histidine intermediate.
Aspartic acid/glutamic acid-specific protein kinases
This section needs expansion. You can help by adding to it. (June 2008) |
Inhibitors
Deregulated kinase activity is a frequent cause of disease, in particular cancer, wherein kinases regulate many aspects that control cell growth, movement and death. Drugs that inhibit specific kinases are being developed to treat several diseases, and some are currently in clinical use, including Gleevec (imatinib) and Iressa (gefitinib).
- Anthra(1,9-cd)pyrazol-6(2H)-one
- Staurosporine
Kinase assays and profiling
Drug developments for kinase inhibitors are started from kinase assays, the lead compounds are usually profiled for specificity before moving into further tests. Many profiling services are available from fluorescent-based assays to radioisotope based detections, and competition binding assays.
References
- S2CID 26554314.
- )
- S2CID 9299657.
- PMID 12531242.
- PMID 12734000.
- S2CID 21377422.
- PMID 1835513.
- )
- PMID 31875044.
- PMID 1862342.
- ^ Higashiyama S, Iwabuki H, Morimoto C, Hieda M, Inoue H, Matsushita N. Membrane-anchored growth factors, the epidermal growth factor family: beyond receptor ligands. Cancer Sci. 2008 Feb;99(2):214-20. Review. PMID: 18271917
- ^ Carpenter G. The EGF receptor: a nexus for trafficking and signaling. Bioessays. 2000 Aug;22(8):697-707. Review. PMID: 10918300
External links
- Human and mouse protein kinases in UniProt: classification and index
- Kinase.Com: Genomics, evolution and large-scale analysis of protein kinases (non-commercial).
- KinMutBase: A registry of disease-causing mutations in protein kinase domains
- KLIFS (Kinase-Ligand Interaction Fingerprints and Structures) Database -- analysis of kinase structures and kinase-inhibitor interactions
- KinCore: the Kinase Conformation Resource: A web resource for protein kinase sequence, structure and phylogeny
- Kinomer: A multilevel HMM library for the classification and functional annotation of eukaryotic protein kinases.